Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lancranjan

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Clinical Endocrinology|May 1, 1986
Parenteral bromocriptine in the treatment of hormonally active pituitary tumoursG Benker, B Gieshoff, O Freundlieb, et al.
Endokrynologia Polska|January 1, 1993
The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemiaM Bolanowski, A Milewicz, A Bohdanowicz-Pawlak, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Sandostatin LAR in acromegalic patients: long-term treatmentA K Fløgstad, J Halse, S Bakke, et al.
Fertility and Sterility|April 1, 1989
Return of gonadotropic function in postpartum women during bromocriptine treatmentJ A Kremer, R Rolland, P F van der Heijden, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegalyA Colao, D Ferone, P Marzullo, et al.
Archiv Fur Gynakologie|September 17, 1976
The influence of the prolactin inhibitor bromocriptin (CB 154) on human luteal function in vivoK D Schulz, W Geiger, E Del Pozo, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1991
Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safetyB Merola, A Colao, E Caruso, et al.
Journal of Endocrinological Investigation|January 1, 1988
Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomasG Schettini, G Lombardi, B Merola, et al.
Clinical Endocrinology|January 1, 1977
Effect of bromocriptin on the endocrine system and fetal developmentE Del Pozo, A Darragh, I Lancranjan, et al.
Journal of Endocrinological Investigation|June 1, 1991
Efficacy and tolerability of a long-acting intramuscularly injectable depot preparation of bromocriptine: the results of a double blind studyA Schulz, I Lancranjan, T Schürmeyer, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Clinical Endocrinology|May 1, 1986
Parenteral bromocriptine in the treatment of hormonally active pituitary tumoursG Benker, B Gieshoff, O Freundlieb, et al.
Endokrynologia Polska|January 1, 1993
The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemiaM Bolanowski, A Milewicz, A Bohdanowicz-Pawlak, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Sandostatin LAR in acromegalic patients: long-term treatmentA K Fløgstad, J Halse, S Bakke, et al.
Fertility and Sterility|April 1, 1989
Return of gonadotropic function in postpartum women during bromocriptine treatmentJ A Kremer, R Rolland, P F van der Heijden, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegalyA Colao, D Ferone, P Marzullo, et al.
Archiv Fur Gynakologie|September 17, 1976
The influence of the prolactin inhibitor bromocriptin (CB 154) on human luteal function in vivoK D Schulz, W Geiger, E Del Pozo, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1991
Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safetyB Merola, A Colao, E Caruso, et al.
Journal of Endocrinological Investigation|January 1, 1988
Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomasG Schettini, G Lombardi, B Merola, et al.
Clinical Endocrinology|January 1, 1977
Effect of bromocriptin on the endocrine system and fetal developmentE Del Pozo, A Darragh, I Lancranjan, et al.
Journal of Endocrinological Investigation|June 1, 1991
Efficacy and tolerability of a long-acting intramuscularly injectable depot preparation of bromocriptine: the results of a double blind studyA Schulz, I Lancranjan, T Schürmeyer, et al.
Pageof 8